← brief for 2026-10-25 · Regeneration & devices

Paclitaxel-induced scleroderma: A scoping review of reported cases with an illustrative case from our center.

Article C Peer reviewed Observational

Key takeaways

This review looked at published cases of a rare skin condition caused by a chemotherapy drug called paclitaxel. It includes a new case from the authors' center. The study shows a link between the drug and the skin condition, but it is not proof of cause. It helps doctors recognize this side effect.

Who did this work

Bogojevic M · Medjedovic R · Janjic NL · Vukovic I · Markovic M · Matucci-Cerinic M

Source

Article · PubMed, fibrosis reversal · 2026 Oct 22
https://pubmed.ncbi.nlm.nih.gov/42924234/